BFO
Boston Family Office Portfolio holdings
AUM $1.51B
1-Year Return
12.61%
This Quarter Return
-16.76%
1 Year Return
+12.61%
3 Year Return
+54.38%
5 Year Return
+90.66%
10 Year Return
+237.26%
AUM
$847M
AUM Growth
-$205M
(-20%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-1.46%
Top 10 Holdings %
Top 10 Hldgs %
27.22%
Holding
257
New
5
Increased
68
Reduced
98
Closed
21
Top Buys
| 1 |
IQVIA
IQV
|
+$1.28M |
| 2 |
Zebra Technologies
ZBRA
|
+$1.13M |
| 3 |
Chevron
CVX
|
+$1.06M |
| 4 |
Boeing
BA
|
+$931K |
| 5 |
Visa
V
|
+$557K |
Top Sells
| 1 |
American Tower
AMT
|
+$2.24M |
| 2 |
Gilead Sciences
GILD
|
+$1.63M |
| 3 |
Exxon Mobil
XOM
|
+$1.3M |
| 4 |
Verizon
VZ
|
+$1.22M |
| 5 |
Marsh & McLennan
MMC
|
+$1.21M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Healthcare | 17.21% |
| 3 | Financials | 9.76% |
| 4 | Industrials | 8.71% |
| 5 | Consumer Staples | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Roper Technologies
ROP
$54.4B
| $9.94M | 1.17% |
31,874
+1,651
| +5% | +$515K |
|
27
Vanguard FTSE Emerging Markets ETF
VWO
$101B
| $9.82M | 1.16% |
292,616
-1,626
| -0.6% | -$54.6K |
|
28
SPDR S&P MidCap 400 ETF Trust
MDY
$23.8B
| $9.66M | 1.14% |
36,755
-2,974
| -7% | -$782K |
|
29
Stryker
SYK
$144B
| $9.46M | 1.12% |
56,847
+597
| +1% | +$99.4K |
|
30
General Mills
GIS
$26.5B
| $9.36M | 1.11% |
177,325
-10,999
| -6% | -$580K |
|
31
CVS Health
CVS
$93.2B
| $8.99M | 1.06% |
151,443
+4,845
| +3% | +$287K |
|
32
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $8.92M | 1.05% |
159,001
-8,667
| -5% | -$486K |
|
33
PepsiCo
PEP
$192B
| $8.9M | 1.05% |
74,071
+403
| +0.5% | +$48.4K |
|
34
Abbott
ABT
$229B
| $8.23M | 0.97% |
104,274
-217
| -0.2% | -$17.1K |
|
|
35
Verizon
VZ
$184B
| $8.09M | 0.96% |
150,650
-22,636
| -13% | -$1.22M |
|
36
Invesco QQQ Trust
QQQ
$374B
| $7.56M | 0.89% |
39,728
+358
| +0.9% | +$68.2K |
|
37
Danaher
DHR
$136B
| $7.1M | 0.84% |
57,896
-527
| -0.9% | -$64.7K |
|
38
TE Connectivity
TEL
$62.8B
| $7.02M | 0.83% |
111,535
-515
| -0.5% | -$32.4K |
|
39
Merck
MRK
$203B
| $6.97M | 0.82% |
94,885
-6,377
| -6% | -$468K |
|
40
S&P Global
SPGI
$166B
| $6.91M | 0.82% |
28,206
| – | – |
|
41
Dollar Tree
DLTR
$19.5B
| $6.85M | 0.81% |
93,281
-1,457
| -2% | -$107K |
|
42
Idexx Laboratories
IDXX
$51.5B
| $6.28M | 0.74% |
25,913
+58
| +0.2% | +$14.1K |
|
|
43
Gilead Sciences
GILD
$140B
| $6.13M | 0.72% |
82,003
-21,759
| -21% | -$1.63M |
|
44
McDonald's
MCD
$216B
| $6.03M | 0.71% |
36,487
-777
| -2% | -$128K |
|
45
AbbVie
ABBV
$382B
| $5.6M | 0.66% |
73,486
-86
| -0.1% | -$6.55K |
|
46
Aflac
AFL
$58B
| $5.47M | 0.65% |
159,652
-389
| -0.2% | -$13.3K |
|
47
JPMorgan Chase
JPM
$850B
| $5.05M | 0.6% |
56,097
-928
| -2% | -$83.5K |
|
48
Adobe
ADBE
$150B
| $4.98M | 0.59% |
15,655
+1,451
| +10% | +$462K |
|
|
49
Chevron
CVX
$321B
| $4.94M | 0.58% |
68,151
+14,628
| +27% | +$1.06M |
|
50
Becton Dickinson
BDX
$53.4B
| $4.88M | 0.58% |
21,767
-872
| -4% | -$195K |
|